ZyVersa Therapeutics’ CEO, Stephen C. Glover to Present at BTIG’s Virtual Biotechnology Conference 2021
- Tuesday, August 3, 2021, 6:24
- Environment
- Add a comment
WESTON, Fla., Aug. 3, 2021 /PRNewswire/ — ZyVersa Therapeutics, Inc. (ZyVersa), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, is pleased to announce that Stephen C. Glover, ZyVersa’s Co-Founder,…
About the Author
adminasapcorp has written 41528 stories on this site.